Valuation DBV Technologies Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate 15:12:04 2026-09-29 EDT			5-day change	1st Jan Change
2.021 ^EUR	+0.15%		-3.37%	-38.22%

09-24	European Equities Traded in the US as American Depositary Receipts Edge Lower in Thursday Trading	MT
09-23	European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	168.2	295.6	178	64.61	678.1	613.1	-	-
Change	-	75.76%	-39.8%	-63.7%	949.56%	-9.58%	-	-
Enterprise Value (EV) ¹	98.88	98.35	48.63	35.95	509.7	537.7	494.1	570.5
Change	-	-0.54%	-50.56%	-26.07%	1,318.01%	5.48%	-8.11%	15.48%
P/E	-0.94x	-1.35x	-1.33x	-1.15x	-7.43x	-4.71x	-14.5x	15.6x
PBR	0.94x	0.81x	0.69x	-	10.9x	8.89x	20.5x	6.08x
PEG	-	0x	0x	0x	0.4x	1.39x	0.2x	-0x
Capitalization / Revenue	32.6x	65.3x	12.4x	16.6x	139x	226x	9.9x	2.8x
EV / Revenue	19.1x	21.7x	3.38x	9.26x	104x	198x	7.98x	2.61x
EV / EBITDA	-1.2x	-1.25x	-0.59x	-	-4.09x	-3.39x	-9.65x	10.5x
EV / EBIT	-1.1x	-1.08x	-0.7x	-0.33x	-4x	-3.05x	-3.79x	-74.9x
EV / FCF	-1.01x	-1.85x	-1.03x	-0.38x	-4.83x	-2.47x	-2.48x	-16x
FCF Yield	-99.1%	-54.1%	-97.5%	-262%	-20.7%	-40.4%	-40.4%	-6.25%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-3.24	-2.339	-1.391	-0.546	-0.4552	-0.4398	-0.143	0.133
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	5.165	4.526	14.39	3.883	4.886	2.715	61.95	218.8
EBITDA ¹	-82.28	-78.71	-82.74	-	-124.7	-158.7	-51.22	54.32
EBIT ¹	-89.75	-90.72	-69.94	-107.7	-127.5	-176.5	-130.4	-7.615
Net income ¹	-144.5	-90.53	-66.54	-105.5	-127.4	-174	-126.1	-14.78
Net Debt ¹	-69.31	-197.3	-129.4	-28.66	-168.3	-75.46	-119.1	-42.61
Reference price ²	3.059	3.146	1.849	0.630	3.380	2.072	2.072	2.072
Nbr of stocks (in thousands)	54,983	93,967	96,256	102,550	200,618	295,915	-	-
Announcement Date	3/3/22	3/2/23	3/7/24	3/24/25	3/26/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MERCK & CO., INC.	108.17x	6.03x	25.58x	2.29%	367B
MERCK KGAA	23.44x	3.16x	11.05x	1.7%	68.44B
HALOZYME THERAPEUTICS, INC.	15.66x	7.64x	11.71x	-	12.81B
KYOWA KIRIN CO., LTD.	14.33x	1.78x	6.05x	3.09%	7.47B
SK BIOPHARMACEUTICALS CO., LTD.	17.99x	5.59x	14.94x	-.--%	4.39B
YUHAN CORPORATION	35.65x	2.34x	26.64x	0.77%	4.1B
BETTA PHARMACEUTICALS CO., LTD.	34.32x	5.38x	15.74x	-	2.99B
SUPERNUS PHARMACEUTICALS, INC.	-223x	-	-	-.--%	2.59B
Average	3.32x	4.56x	15.96x	1.31%	58.7B
Weighted average by Cap.	88.04x	5.54x	22.60x	2.17%